• TRADE NAME: AdreView (GE Healthcare)
  • INDICATIONS: Detection of primary or metastatic pheochromocytoma or neuroblastoma as an adjunct to other diagnostic tests
  • SYNONYM: metaiodobenzylguanidine; MIBG
  • CLASS: Radiopharmaceutical, diagnostic agent
  • HALF-LIFE: 13 hours

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric